OTTAWA, June 9, 2014 /CNW/ - Health Canada is informing Canadians that
it has suspended the establishment licence of Canadadrugs.com LP, of Winnipeg, Manitoba, due to significant concerns with Good
Manufacturing Practices (GMP) discovered during an inspection of its
drug wholesaling activities. Wholesaling involves the sale of drug
products from manufacturers and importers to pharmacies.
The suspension of the establishment license means Canadadrugs.com is not
permitted to wholesale drugs to retail pharmacies, other distributors
or wholesalers until these concerns are fully addressed and the
establishment licence is reinstated.
To receive and maintain an establishment licence in Canada, a company
must comply with GMP requirements as part of the Food and Drug Regulations, which help to ensure that the drugs sold in Canada are safe, effective
and of high quality. These guidelines are applied to all companies and
are widely known.
Canadadrugs.com is also separately licensed as a pharmacy by the College
of Pharmacists of Manitoba to sell drugs authorized in Canada to
consumers via the internet. In Canada, the provincial and territorial
governments are responsible for regulating the practice of pharmacy
through their colleges or registrars of physicians and/or pharmacists.
As the pharmacy license issued by the College of Pharmacists of Manitoba
is still valid, Canadians are still able to purchase their drugs from
Health Canada has notified the College of Pharmacists of Manitoba
regarding its inspection findings and the suspension of Canadadrugs.com
LP's establishment licence.
SOURCE: Health Canada
For further information:
Également disponible en français